Medicare AdvantageDocumentationMedium impact
[California] Medication safety alerts: reducing opioid and anticholinergic risk
Anthem BCBS·CA · Geriatrics, Internal Medicine, Family Medicine +3 more·Provider Bulletin
Effective date
Jun 30, 2026
We identified it
Jul 1, 2026
Summary
Anthem Blue Cross (California) is implementing enhanced medication safety monitoring for Medicare Advantage members to reduce opioid/benzodiazepine overdose risk and anticholinergic-related falls in older adults. This aligns with CMS Part D Star Measures and requires providers to identify high-risk medication combinations, perform medication reconciliation at every visit, and implement deprescribing strategies. While not a billing code change, this affects clinical documentation and prior authorization practices for affected medication combinations.
Action Required
Effective immediately (June 30, 2026): (1) Billing and clinical teams must implement medication reconciliation protocols at every patient visit and transition of care. (2) Update EHR systems to flag high-risk combinations: opioid + benzodiazepine overlap (≥30 cumulative days) and multiple anticholinergics in patients ≥65 years (≥2 concurrent medications for ≥30 days). (3) Establish prior authorization review process for flagged medication combinations before filling prescriptions. (4) Providers must document deprescribing rationale in medical records when reducing opioid/benzodiazepine overlap or anticholinergic burden. (5) Train billing staff to recognize these medication flags on claims—do not process without clinical review. (6) Ensure PDMP (Prescription Drug Monitoring Program) checks are documented for all opioid prescriptions. Failure to implement these controls may result in Medicare Advantage quality measure penalties and potential claim denials for inadequately justified high-risk medication combinations.